{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:45:06Z","timestamp":1794552306521,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22\/01587"],"award-info":[{"award-number":["PI22\/01587"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ymgme.2025.109023","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:09:37Z","timestamp":1737418177000},"page":"109023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Comprehensive analysis of GDF15 as a biomarker in primary mitochondrial myopathies"],"prefix":"10.1016","volume":"144","author":[{"given":"Paloma","family":"Mart\u00edn-Jimenez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bermejo-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Navarro-Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Serrano-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Garrido-Moraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Hern\u00e1ndez-La\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Hern\u00e1ndez-Voth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Dom\u00ednguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109023_bb0005","series-title":"GeneReviews\u00ae","article-title":"Primary mitochondrial disorders overview","author":"Chinnery","year":"1993"},{"key":"10.1016\/j.ymgme.2025.109023_bb0010","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.nmd.2017.08.006","article-title":"International Workshop","volume":"27","author":"Mancuso","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2025.109023_bb0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/jmedgenet-2019-106649","article-title":"Clinical, pathological and genetic spectrum in 89 cases of mitochondrial progressive external ophthalmoplegia","volume":"57","author":"Rodr\u00edguez-L\u00f3pez","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2025.109023_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jcm11010022","article-title":"Clinical, histological, and genetic features of 25 patients with autosomal dominant progressive external Ophthalmoplegia (ad-PEO)\/PEO-plus due to TWNK mutations","volume":"11","author":"Bermejo-Guerrero","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2025.109023_bb0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000519","article-title":"Primary mitochondrial myopathy: clinical features and outcome measures in 118 cases from Italy","volume":"6","author":"Montano","year":"2020","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.ymgme.2025.109023_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/B978-0-12-821751-1.00018-X","article-title":"Progressive external ophthalmoplegia","volume":"194","author":"Hirano","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ymgme.2025.109023_bb0035","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/jcm11030632","article-title":"Molecular genetics overview of primary mitochondrial myopathies","volume":"11","author":"Arena","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2025.109023_bb0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10545-017-0027-5","article-title":"MtDNA-maintenance defects: syndromes and genes","volume":"40","author":"Viscomi","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109023_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.19","article-title":"Biomarkers-A general review","volume":"76","author":"Aronson","year":"2017","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.ymgme.2025.109023_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129834","article-title":"GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH","volume":"1865","author":"Kim","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ymgme.2025.109023_bb0055","doi-asserted-by":"crossref","first-page":"102181","DOI":"10.1016\/j.isci.2021.102181","article-title":"Differential roles of GDF15 and FGF21 in systemic metabolic adaptation to the mitochondrial integrated stress response","volume":"24","author":"Kang","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ymgme.2025.109023_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2164-15-91","article-title":"Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies","volume":"15","author":"Kalko","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ymgme.2025.109023_bb0065","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1007\/s12035-016-0283-7","article-title":"Growth differentiation factor 15 is a novel diagnostic biomarker of mitochondrial diseases","volume":"54","author":"Ji","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymgme.2025.109023_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.mito.2021.10.008","article-title":"Blood biomarkers for assessment of mitochondrial dysfunction: an expert review","volume":"62","author":"Hubens","year":"2022","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2025.109023_bb0075","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.0000000000002705","article-title":"A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases","volume":"86","author":"Davis","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2025.109023_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jimd.12307","article-title":"Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease","volume":"44","author":"Lehtonen","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109023_bb0085","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.24506","article-title":"Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders","volume":"78","author":"Yatsuga","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2025.109023_bb0090","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/B978-0-12-821751-1.00006-3","article-title":"Blood biomarkers of mitochondrial disease\u2014One for all or all for one?","author":"Suomalainen","year":"2023"},{"key":"10.1016\/j.ymgme.2025.109023_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101879","article-title":"Remarkable clinical improvement with oral nucleoside treatment in a patient with adult-onset TK2 deficiency: A case report","volume":"76","author":"Bermejo-Guerrero","year":"2024","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2025.109023_bb0100","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1038\/s41598-020-66940-8","article-title":"Growth differentiation factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy","volume":"10","author":"Dominguez-Gonzalez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2025.109023_bb0105","series-title":"THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study - Mcdonald","year":"2013"},{"key":"10.1016\/j.ymgme.2025.109023_bb0110","series-title":"Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy - Mayhew","year":"2013"},{"key":"10.1016\/j.ymgme.2025.109023_bb0115","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1515\/cclm-2018-0534","article-title":"Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD)","volume":"57","author":"Hamon","year":"2019","journal-title":"Clin. Chem. Lab. Med. CCLM."},{"key":"10.1016\/j.ymgme.2025.109023_bb0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.25506","article-title":"Deoxynucleoside therapy for thymidine kinase 2-deficient myopathy","volume":"86","author":"Dom\u00ednguez-Gonz\u00e1lez","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2025.109023_bb0125","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200138","article-title":"For TK2d Spanish-group: clinical and genetic analysis of patients with TK2 deficiency","volume":"10","author":"Ceballos","year":"2024","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.ymgme.2025.109023_bb0130","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/ajrccm.158.5.9710086","article-title":"Reference equations for the six-minute walk in healthy adults","volume":"158","author":"Enright","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2025.109023_bb0135","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/mus.27543","article-title":"Factors impacting performance on the 6-minute walk test by people with late-onset Pompe disease","volume":"65","author":"Tard","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2025.109023_bb0140","first-page":"689","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"10.1016\/j.ymgme.2025.109023_bb0145","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1542\/peds.35.2.322","article-title":"The diagnostic value of serum Creatine kinase in neuromuscular and muscular disease","volume":"35","author":"Vassella","year":"1965","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2025.109023_bb0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13023-019-1071-z","article-title":"Late-onset thymidine kinase 2 deficiency: a review of 18 cases","volume":"14","author":"Dom\u00ednguez-Gonz\u00e1lez","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109023_bb0155","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.3390\/ijms231911002","article-title":"Pathological features in Paediatric patients with TK2 deficiency","volume":"23","author":"Jou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109023_bb0160","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fneur.2017.00196","article-title":"Serum creatinine distinguishes Duchenne muscular dystrophy from Becker muscular dystrophy in patients aged \u22643 years: A retrospective study","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2025.109023_bb0165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/acn3.51299","article-title":"Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis","volume":"8","author":"Guo","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymgme.2025.109023_bb0170","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1073\/pnas.0906039107","article-title":"A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells","volume":"107","author":"Shaham","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2025.109023_bb0175","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.nmd.2022.07.399","article-title":"Metrics of progression and prognosis in untreated adults with thymidine kinase 2 deficiency: an observational study","volume":"32","author":"Dom\u00ednguez-Gonz\u00e1lez","year":"2022","journal-title":"Neuromuscul. Disord. NMD."},{"key":"10.1016\/j.ymgme.2025.109023_bb0180","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1212\/WNL.55.11.1748","article-title":"A placebo-controlled crossover trial of creatine in mitochondrial diseases","volume":"55","author":"Klopstock","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2025.109023_bb0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0887-8994(02)00469-1","article-title":"Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies","volume":"28","author":"Komura","year":"2003","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2025.109023_bb0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4020-6486-9_10","article-title":"Clinical use of creatine in neuromuscular and neurometabolic disorders","volume":"46","author":"Tarnopolsky","year":"2007","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ymgme.2025.109023_bb0195","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jimd.12142","article-title":"Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders","volume":"42","author":"Tsygankova","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109023_bb0200","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3390\/jcm12062435","article-title":"Serum GDF-15 levels accurately differentiate patients with primary mitochondrial myopathy, manifesting with exercise intolerance and fatigue, from patients with chronic fatigue syndrome","volume":"12","author":"Bermejo-Guerrero","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2025.109023_bb0205","article-title":"Circulating FGF21 and GDF15 as biomarkers for screening, diagnosis, and severity assessment of primary mitochondrial disorders in children","volume":"10","author":"Li","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109023_bb0210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/brain\/awt321","article-title":"Disease progression in patients with single, large-scale mitochondrial DNA deletions","volume":"137","author":"Grady","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2025.109023_bb0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mito.2019.10.001","article-title":"A novel mutation in the mitochondrial MT-ND5 gene in a family with MELAS. The relevance of genetic analysis on targeted tissues","volume":"50","author":"Panad\u00e9s-de Oliveira","year":"2020","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2025.109023_bb0220","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708262","article-title":"mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease","volume":"10","author":"Grady","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgme.2025.109023_bb0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/mus.23905","article-title":"The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study","volume":"48","author":"McDonald","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2025.109023_bb0230","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jimd.12320","article-title":"Seeking impact: global perspectives on outcome measure selection for translational and clinical research for primary mitochondrial disorders","volume":"44","author":"Goldstein","year":"2021","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:10:58Z","timestamp":1744416658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1096719225000149"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109023","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of GDF15 as a biomarker in primary mitochondrial myopathies","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109023"}}